Dr. Hermel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10710 N Torrey Pines Rd
La Jolla, CA 92037Phone+1 858-554-8788Fax+1 858-554-8946
Summary
- Dr. David Hermel is currently a hematologist at Scripps Clinic in La Jolla, CA. He completed his fellowship in hematology and oncology at Scripps Clinic and his residency training in internal medicine at the University of Southern California. He received his medical degree from the University of Vermont College of Medicine and completed undergraduate studies at the University of California, Los Angeles.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2016 - 2019
- University of Vermont College of MedicineClass of 2016
Certifications & Licensure
- CA State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 21 citationsMental stress peripheral vascular reactivity is elevated in women with coronary vascular dysfunction: Results from the NHLBI-sponsored Cardiac Autonomic Nervous System...Puja K. Mehta, Melody H. Hermel, Michael D. Nelson, Galen Cook-Wiens, Elizabeth A. Martin
International Journal of Cardiology. 2018-01-15 - 4 citationsCardiac Sympathetic Activity by 123I-Meta-Iodobenzylguanidine Imaging in Women With Coronary Microvascular Dysfunction: A Pilot Study.Puja K. Mehta, Louise Thomson, Piotr J. Slomka, Sean W. Hayes, John D. Friedman
JACC. Cardiovascular Imaging. 2021-09-01 - 2 citationsCurated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.Alexander Karabachev, Dylan J. Martini, David J. Hermel, Dana Solcz, Marcy E. Richardson
Plos One. 2020-08-04
Journal Articles
- Progress in gastrointestinal cancer immunotherapyDavid J. Hermel, Melody H. Hermel, Darren S. Sigal, Translational Cancer Research, 2/2017
- “Check”-ing the Data: A Review of Immune Checkpoint Inhibitor BiomarkersHermel D, Sigal D, Personalized Medicine in Oncology, 8/1/2016
Books/Book Chapters
Abstracts/Posters
- Expanded Panel Testing in Patients with Breast or Ovarian Cancer in a Rural Familial Cancer ProgramHermel D.J., McKinnon W.C., Colello L., Greenblatt M.S., Wood M.E, Cancer Research
- Tacrolimus Is Effective Immunosuppressive Therapy in Aplastic AnemiaChiu V., Hermel D.J., Weitz I.C, Blood
- PD-1 Inhibition in Cutaneous Squamous Cell CarcinomaHermel D.J., Ragab O., Higgins S., Wysong A., In G.K, ASCO
- Join now to see all
Press Mentions
- Reducing Hospital Length of Stay for AML Patients on High-Dose CytarabineDecember 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: